Reuters logo
1 个月前
BRIEF-Newron Pharmaceuticals: Xadago available in U.S. for Parkinson's disease patients​
2017年7月11日 / 中午11点34分 / 1 个月前

BRIEF-Newron Pharmaceuticals: Xadago available in U.S. for Parkinson's disease patients​

July 11 (Reuters) - NEWRON PHARMACEUTICALS SPA:

* ‍XADAGO(R) (SAFINAMIDE) NOW AVAILABLE IN U.S. FOR PARKINSON'S DISEASE PATIENTS​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below